Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nautilus Biotechnology (NAUT) Capital Expenditures (2020 - 2026)

Nautilus Biotechnology has reported Capital Expenditures over the past 7 years, most recently at $510000.0 for Q1 2026.

  • Quarterly results put Capital Expenditures at $510000.0 for Q1 2026, up 132.88% from a year ago — trailing twelve months through Mar 2026 was $1.6 million (down 7.44% YoY), and the annual figure for FY2025 was $1.3 million, down 39.82%.
  • Capital Expenditures reached $510000.0 in Q1 2026 per NAUT's latest filing, up from $244000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $963000.0 in Q3 2022 and bottomed at $219000.0 in Q1 2025.
  • Median Capital Expenditures over the past 5 years was $481000.0 (2022), compared with a mean of $510294.1.
  • Peak annual rise in Capital Expenditures hit 256.67% in 2022, while the deepest fall reached 76.77% in 2022.
  • Over 5 years, Capital Expenditures stood at $229000.0 in 2022, then skyrocketed by 80.35% to $413000.0 in 2023, then crashed by 38.5% to $254000.0 in 2024, then decreased by 3.94% to $244000.0 in 2025, then surged by 109.02% to $510000.0 in 2026.
  • Business Quant data shows Capital Expenditures for NAUT at $510000.0 in Q1 2026, $244000.0 in Q4 2025, and $418000.0 in Q3 2025.